We recently sat down with Dr. Ora Gordon, a self-proclaimed preventionist, to learn about Providence investments in genetics and genomics. From the role biomarkers play in creating targeted treatments for individuals to the launch of a study called Geno4ME to sequence the genetic makeup of 5,000 adults in 2021, Dr. Gordon offers an informed glimpse into the future of personalized medicine.